FOLD earnings: a negative outcome, -6.5%

On May 9, 2024, Amicus Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.5% in the window around the event. It had already run -12.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.